We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

About CCS Heart Failure Guidelines

2012 Heart Failure and 2013 Cardiac Resynchronization Therapy Guidelines

CCS is retiring this app - Get the new iCCS all-in-one app today! It has the latest guidelines for HF, AF, CRT, Lipids, AP, and Drive/Fly.

The CCS Heart Failure Guidelines App is based on the updated 2012 society Heart Failure (HF) guidelines and the 2013 Cardiac Resynchronization Therapy (CRT) guidelines of 2013. This App facilitates the adoption of the CCS Heart Failure guidelines into daily clinical practice by healthcare professionals.

Features:

• Videos that provide an overview of the 2012 HF guideline updates.

• Recommendations with key figures and tables

• Tools (PRIDE Acute HF Score & Framingham Heart Score)

• Useful drug and treatment information

• Landmark heart failure clinical trial summaries and key references

• Guideline library that contains all the CCS HF & CRT Guidelines and Updates between 2002-2013

Note: The default keyboard on certain devices may not contain a comma, which is needed for some tools. If so, please install the default Google Keyboard: https://play.google.com/store/apps/details?id=com.google.android.inputmethod.latin

What's New in the Latest Version 2.5.0

Last updated on Aug 12, 2015

• Maintenance Fixes

Translation Loading...

Additional APP Information

Latest Version

Request CCS Heart Failure Guidelines Update 2.5.0

Uploaded by

Peshraw Shahana

Requires Android

Android 3.0+

Show More

CCS Heart Failure Guidelines Screenshots

Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.